Join policymakers, industry leaders and investors to explore how regulatory approvals, investment incentives, green procurement, bio-based content requirements and other market-pull measures; such as Malaysia’s BioNexus Status, India’s BioE3 Policy, Korea’s Synthetic Biology Promotion Act and similar initiatives across the region can create stronger demand, attract investment and support commercial-scale deployment.

APAC has a rich and diverse range of biomass resources, from agricultural residues such as rice husks, palm waste and sugarcane bagasse, to forestry by-products like wood chips and sawdust, food and agricultural processing waste, livestock waste streams, industrial CO₂ emissions and manufacturing residues, as well as marine biomass including algae and seaweed, along with other organic waste streams. Explore how these diverse feedstocks can be converted into scalable biobased products, materials, chemicals and other industrial applications across APAC.

Moving from lab to commercial production remains one of the biggest hurdles for industrial biomanufacturing. Explore the key barriers to scaling, including process optimisation at larger volumes, high production costs, limited demonstration and commercial-scale infrastructure, financing gaps, regulatory complexity, and securing long-term customer demand. Hear how companies that have successfully scaled overcame these challenges and what it takes to achieve commercial success.

How bio-based solutions can match and in some cases outperform petrochemicals on cost, scale and performance. Explore where bio-based materials are already being used in real-world applications, including sustainable packaging, biodegradable and high-performance polymers, bio-based solvents, and others, how advances in fermentation, bioprocessing and industrial biotechnology are improving production efficiency, consistency and scalability, while enabling bio-based solutions that not only close the cost gap but also deliver improved material performance such as durability, strength and functionality, alongside advantages in carbon footprint, regulatory compliance and product innovation.

Hearing directly from buyers on what drives adoption decisions in bio-based solutions. Beyond sustainability claims, buyers are looking for solutions that can compete with petrochemical products in real-world performance including strength, durability, reliability in processing, and consistent quality at scale alongside cost competitiveness, supply security and regulatory compliance. Explore the practical expectations suppliers must meet to move from lab to commercial adoption.

Bringing industrial biomanufacturing from lab to commercial scale requires significant investment, yet many projects struggle with high upfront costs, technology risk, long payback periods and limited access to finance. Learn how investors, governments, development banks, and financing models are helping unlock capital, reduce risk and accelerate commercial deployment.

AI is no longer just a research tool, it is helping companies design better microbes, optimise fermentation, monitor production in real time and improve product quality. Learn how AI is reducing trial-and-error, increasing yields, cutting costs and helping manufacturers bring bio-based innovations to market faster.

Geopolitical tensions, supply chain disruptions, energy price volatility and changing trade policies have renewed interest in bio-based manufacturing by highlighting the risks of relying on fossil-based supply chains. But when oil prices fall and global markets stabilise, can bio-based industries remain commercially competitive? Explore how companies are building resilient business models that can withstand changing market conditions while strengthening regional supply chains and long-term competitiveness across APAC.